Hep Web Exclusives : 2012 Top Hepatitis Stories
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hep Web Exclusives » December 2012


December 10, 2012

2012 Top Hepatitis Stories

Here are the top hepatitis stories by pageviews this year:

1. Breakthrough: Non-Interferon/Ribavirin Regimen Can Cure Hep C
Posted: April 4

2. Gilead’s Hep C Combo Therapy Shows 100% Cure Rate in Small Study
Posted: November 14

3. Efficacy of 12-Week GS-7977/Ribavirin Combo for Hep C Geno 1 Varies by IL-28B Status
Posted: April 23

4. Hep C Now Trumps HIV as Cause of Death in U.S.
Posted: February 21

5. Daclatasvir, Sofosbuvir Combo Boasts High Hep C Cure Rates Across Genotypes
Posted: November 20

6. Interferon-Free BMS Combo Yields 77% Cure Rate in Geno 1 Hep C
Posted: April 24

7. Experts Issue Early Guide for Hep C Protease Inhibitor Therapy in People Living with HIV
Posted: January 3

8. Interferon-Free Gilead and BMS Combo Shows High Cure Rate Potential
Posted: April 20

9. Hepatitis C Antiviral Treatments May Prevent Liver Cancer
Posted: October 29

10. Incivek, Victrelis Associated With Serious Side Effects in Cirrhotic Patients
Posted: April 24

11. Incivek, Victrelis Studies Hint at Superior Cure Rates in HIV/HCV Coinfection
Posted: March 6

12. Marker of Active Hep B Infection Declines in Those Coinfected with HIV, Treated with Tenofovir
Posted: March 20

13. Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors
Posted: March 1

14. PILOT Study: Three-Month Interferon-Free Regimen Cures 9 of 11 Geno 1, IL-28B CC Hep C Patients
Posted: April 23

15. TMC435 Boosts Cure Rates in Previously Treated Geno 1 HCV Patients
Posted: April 19

16. Clearing or Curing Acute HCV Does Not Protect Against Reinfection
Posted: March 26

17. Novel Lambda Peg-Interferon Has Safety Edge Over Approved Peg-Interferon
Posted: April 20

18. Victrelis Shows Effectiveness for Prior Treatment Null Responders
Posted: April 19

19. Hep C Protease Inhibitor Incivek Is Safe, Effective for HIV Coinfection
Posted: November 15

20. Abbott’s Interferon-Free Hep C Regimen Boasts Over 90% Cure Rates
Posted: November 13

Search: hepatitis, hepatitis c, hepatitis b, gilead, bms, vertex, merck, abbott, janssen

Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
Current Issue
Hep TV
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Should Medicaid limit access to new hep C drugs?

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.